Clinical Trials Logo

Clinical Trial Summary

Occurrence of venous thromboembolism during in Vitro Fertilization (IVF) pregnancies has been reported in numerous case reports and in two small consecutive series. The incidence of venous thromboembolism (VTE) after IVF has been claimed to be comparable to the incidence of VTE during normal pregnancy. No information exists concerning pulmonary embolism (PE).

The aim is to estimate and compare the risk of both PE and VTE during the the different phases of pregnancy after IVF to that in age and period matched control women. The investigators will use the Swedish National Health Registers to estimate the risk.


Clinical Trial Description

Background: Occurrence of venous thromboembolism (VTE) during IVF pregnancies has been reported in numerous case reports and in two small consecutive series. The incidence of VTE after IVF has been claimed to be comparable to the incidence of VTE during normal pregnancy. No information exists concerning pulmonary embolism (PE).

Aim: The aim is to estimate and compare the risk of both PE and VTE during the trimesters of pregnancy after IVF to that in age and period matched control women.

Design and methods: A cross-sectional study using linkage of Swedish population and health registers. The Swedish National Patient Register encompasses inpatients and outpatients. Inpatient data in Sweden is available nationwide since 1987. Outpatient diagnoses from hospitals started to be collected in 1997. Data in the Patient Register will be linked to the Swedish Medical Birth Register (MBR) at the National Board of Health and Welfare through the unique personal identity number assigned to all Swedish residents, Exposed women: Mothers who had given birth to a child as a result of IVF will be retrieved from the Swedish IVF Register at the National Board of Health and Welfare. The Swedish IVF Register is now a part of the Swedish Medical Birth Register (MBR) at the National Board of Health and Welfare and includes information on IVF pregnancies since 1982.

We will restrict the retrieval to mothers of a child born as from 1990 until 2008 and who had their first child born after assisted reproduction by IVF.

Unexposed women: Each IVF woman will be matched with 5 unexposed women from the MBR by calendar year of delivery and maternal age.

Information will be retrieved on country of birth, pre-pregnancy body mass index, family situation, cigarette smoking habits, number of older siblings, singleton/multiple births, and estimated length of gestation from the MBR register. Dates of the trimesters is calculated from the length of gestation. Women´s education is found in the Register of Education, Statistics Sweden, by linkage through the personal identity number.

Diagnoses of VTE including PE will be found by linkage to the Swedish Patient Register of the National Board of Health and Welfare. This register comprises date of admission and discharge, and main diagnosis with up to seven contributing diagnoses. Diagnoses are recorded according to the International Classification of Diagnoses (ICD), ninth version prior to 1996 and the tenth version from 1997. Codes used were 415B, 451B, 452, 453C-D, 453W, 453X, 673C, 671D-E, 671F in ICD9 and I260, I269, I801- 3, I808-9, I822-3, I828-9, O223, O225, O871, O873, O879, O882 in ICD10.

The study is approved by the Research Ethics Committee of Karolinska Institutet, Stockholm, Sweden (Dnr 2010/267-31/4). ;


Study Design

Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT01524393
Study type Observational
Source Danderyd Hospital
Contact
Status Completed
Phase N/A
Start date January 1990
Completion date December 2010

See also
  Status Clinical Trial Phase
Recruiting NCT05050617 - Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
Terminated NCT04558125 - Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism Phase 4
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Completed NCT03915925 - Short-term Clinical Deterioration After Acute Pulmonary Embolism
Completed NCT02502396 - Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
Recruiting NCT05171075 - A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE Phase 3
Completed NCT04454554 - Prevalence of Pulmonary Embolism in Patients With Dyspnea on Exertion (PEDIS)
Completed NCT03173066 - Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography Phase 1
Terminated NCT03002467 - Impact Analysis of Prognostic Stratification for Pulmonary Embolism N/A
Completed NCT02611115 - Optimizing Protocols for the Individual Patient in CT Pulmonary Angiography. N/A
Completed NCT02334007 - Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery Phase 1/Phase 2
Completed NCT01975090 - The SENTRY Clinical Study N/A
Not yet recruiting NCT01357941 - Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE) N/A
Completed NCT01326507 - Prognostic Value of Heart-type Fatty Acid-Binding Protein (h-FABP) in Acute Pulmonary Embolism N/A
Completed NCT00780767 - Angiojet Rheolytic Thrombectomy in Case of Massive Pulmonary Embolism Phase 2
Completed NCT00773448 - Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism N/A
Completed NCT00771303 - Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
Completed NCT02476526 - Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease Phase 4
Completed NCT00720915 - D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months N/A
Completed NCT00244725 - Odiparcil For The Prevention Of Venous Thromboembolism Phase 2